Company performance
Add to research
Current Price
as of Jun 18, 2025$0.80
P/E Ratio
N/A
Market Cap
$103.75M
Description
Add to research
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Metrics
Add to research
Overview
- HQSeattle, WA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerATOS
- Price$0.8032-0.90%
Trading Information
- Market cap$103.75M
- Float99.96%
- Average Daily Volume (1m)656,413
- Average Daily Volume (3m)694,740
- EPS-$0.21
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$6.72M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$7.41M
- EV$21.69M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.59
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Factset